Skip to content

Proteomic study during perioperation of liver transplantation

Proteomic study during perioperation of liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PNRC-08000043
Enrollment
Unknown
Registered
2008-01-22
Start date
2007-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who need liver transplantation due to liver cirrhosis caused by hepatitis B virus infection or liver cancer

Interventions

Control group:Proteomic chip study with plasm after anesthesia, 3 hours and 24 hours later after transplantation
Experimental group:Proteomic chip study with plasm after anesthesia, 3 hours and 24 hours later after transplantation

Sponsors

Third Affiliated Hospital of Sun Yat Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who need liver transplantation due to liver cirrhosis caused by hepatitis B virus infection or liver cancer, no gender preference, no evidence of multiple organs dysfunction before operation (except for the hepatic function) and occurrence of multiple organs dysfunction within 7 days after operation.

Exclusion criteria

Exclusion criteria: Patients who need liver transplantation due to other caused than liver cirrhosis caused by hepatitis B virus infection or liver cancer, having evidence of multiple organs dysfunction before operation (except for the hepatic function) or do not occur multiple organs dysfunction within 7 days after operation.

Design outcomes

Primary

MeasureTime frame
Types, quantity and function of differential expressed protein;

Countries

China

Contacts

Public ContactZiqing Hei
heiziqing@sohu.com+86 020 85252297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026